Human papillomavirus expression and p53 gene mutations in squamous cell carcinoma. 1997

L G Portugal, and J D Goldenberg, and B L Wenig, and K T Ferrer, and E Nodzenski, and J B Sabnani, and C Javier, and R R Weichselbaum, and E E Vokes
Department of Otolaryngology-Head and Neck Surgery, University of Illinois at Chicago, USA.

OBJECTIVE To determine the incidence of human papillomavirus (HPV) infection and p53 gene mutation expression in squamous cell carcinomas (SCCs) of the oral cavity and tonsils, to correlate the presence of HPV and p53 gene mutation with known clinical and pathological features of SCC, and to determine whether infection with HPV or the presence of p53 gene mutations are independent prognosticators of patient survival. METHODS To accomplish this goal, 58 patients with SCCs of the oral cavity and 42 patients with SCCs of the tonsils were randomly examined. The cases examined met the criteria of 5-year clinical follow-up, availability of complete staging information and treatment history, and the presence of paraffin-embedded tumor specimens. Immunohistochemical tests were performed to identify the mutant p53 protein. Human papillomavirus identification was accomplished with polymerase chain reaction, with confirmation via restriction fragment length polymorphisms. RESULTS The incidence of p53 gene mutation expression for this series was 66%. Human papillomavirus infection was found in 11 patients (11%). There was a trend toward increased p53 gene mutation expression with advancing stage of tumor in the oral cavity cancer group, although this was less evident in the tonsil cancer population. The p53 gene mutation status was found not to correlate with the histological grade of the tumor, patient age or sex, recurrence rates, or survival status. Like p53 expression, there were no correlations found between the presence of HPV and age, sex, histological grade, or recurrence rates. However, a correlation did exist between HPV and survival status in the tonsil cancer group, with improved survival noted among patients with tonsil cancers infected with HPV compared with those not infected with HPV. A significant correlation existed with both p53 gene mutation status and HPV status with respect to alcohol and tobacco use. The presence of the p53 gene mutation positively correlated with increased tobacco and alcohol use, whereas infection with HPV predicted a significantly lower rate of alcohol and tobacco consumption. CONCLUSIONS Human papillomavirus infection is an independent risk factor for the development of oral cavity and tonsil SCCs in those patients with a relatively low alcohol and tobacco use history. Conversely, there is a strong association between heavy alcohol and tobacco use and mutation of the p53 gene. Neither p53 gene mutation nor HPV infection serve as prognosticators of tumor behavior in SCCs of the oral cavity or tonsils, with the exception of improved survival noted among patients with tonsil cancers infected with HPV.

UI MeSH Term Description Entries
D009062 Mouth Neoplasms Tumors or cancer of the MOUTH. Cancer of Mouth,Mouth Cancer,Oral Cancer,Oral Neoplasms,Cancer of the Mouth,Neoplasms, Mouth,Neoplasms, Oral,Cancer, Mouth,Cancer, Oral,Cancers, Mouth,Cancers, Oral,Mouth Cancers,Mouth Neoplasm,Neoplasm, Mouth,Neoplasm, Oral,Oral Cancers,Oral Neoplasm
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000428 Alcohol Drinking Behaviors associated with the ingesting of ALCOHOLIC BEVERAGES, including social drinking. Alcohol Consumption,Alcohol Intake,Drinking, Alcohol,Alcohol Drinking Habits,Alcohol Drinking Habit,Alcohol Intakes,Consumption, Alcohol,Drinking Habit, Alcohol,Habit, Alcohol Drinking,Habits, Alcohol Drinking,Intake, Alcohol
D012907 Smoking Willful or deliberate act of inhaling and exhaling SMOKE from burning substances or agents held by hand. Smoking Behaviors,Smoking Habit,Behavior, Smoking,Behaviors, Smoking,Habit, Smoking,Habits, Smoking,Smoking Behavior,Smoking Habits
D014067 Tonsillar Neoplasms Tumors or cancer of the PALATINE TONSIL. Cancer of Tonsil,Tonsillar Cancer,Cancer of the Tonsil,Neoplasms, Tonsil,Neoplasms, Tonsillar,Tonsil Cancer,Tonsil Neoplasms,Cancer, Tonsil,Cancer, Tonsillar,Cancers, Tonsil,Cancers, Tonsillar,Neoplasm, Tonsil,Neoplasm, Tonsillar,Tonsil Cancers,Tonsil Neoplasm,Tonsillar Cancers,Tonsillar Neoplasm
D014412 Tumor Virus Infections Infections produced by oncogenic viruses. The infections caused by DNA viruses are less numerous but more diverse than those caused by the RNA oncogenic viruses. Fibroma, Shope,Papilloma, Shope,Infections, Tumor Virus,Infection, Tumor Virus,Shope Fibroma,Shope Papilloma,Tumor Virus Infection
D015870 Gene Expression The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION. Expression, Gene,Expressions, Gene,Gene Expressions

Related Publications

L G Portugal, and J D Goldenberg, and B L Wenig, and K T Ferrer, and E Nodzenski, and J B Sabnani, and C Javier, and R R Weichselbaum, and E E Vokes
November 1995, British journal of cancer,
L G Portugal, and J D Goldenberg, and B L Wenig, and K T Ferrer, and E Nodzenski, and J B Sabnani, and C Javier, and R R Weichselbaum, and E E Vokes
August 1998, British journal of cancer,
L G Portugal, and J D Goldenberg, and B L Wenig, and K T Ferrer, and E Nodzenski, and J B Sabnani, and C Javier, and R R Weichselbaum, and E E Vokes
March 2000, Cornea,
L G Portugal, and J D Goldenberg, and B L Wenig, and K T Ferrer, and E Nodzenski, and J B Sabnani, and C Javier, and R R Weichselbaum, and E E Vokes
April 2014, Cancer science,
L G Portugal, and J D Goldenberg, and B L Wenig, and K T Ferrer, and E Nodzenski, and J B Sabnani, and C Javier, and R R Weichselbaum, and E E Vokes
November 2000, The Chinese journal of dental research,
L G Portugal, and J D Goldenberg, and B L Wenig, and K T Ferrer, and E Nodzenski, and J B Sabnani, and C Javier, and R R Weichselbaum, and E E Vokes
January 2008, Clinical cancer research : an official journal of the American Association for Cancer Research,
L G Portugal, and J D Goldenberg, and B L Wenig, and K T Ferrer, and E Nodzenski, and J B Sabnani, and C Javier, and R R Weichselbaum, and E E Vokes
September 2003, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
L G Portugal, and J D Goldenberg, and B L Wenig, and K T Ferrer, and E Nodzenski, and J B Sabnani, and C Javier, and R R Weichselbaum, and E E Vokes
December 2005, Zhonghua bing li xue za zhi = Chinese journal of pathology,
L G Portugal, and J D Goldenberg, and B L Wenig, and K T Ferrer, and E Nodzenski, and J B Sabnani, and C Javier, and R R Weichselbaum, and E E Vokes
November 1997, International journal of oncology,
L G Portugal, and J D Goldenberg, and B L Wenig, and K T Ferrer, and E Nodzenski, and J B Sabnani, and C Javier, and R R Weichselbaum, and E E Vokes
May 1999, [Zhonghua yan ke za zhi] Chinese journal of ophthalmology,
Copied contents to your clipboard!